Evidence map›Paper›PMID 38349776›Full record

Trial reportClinical journal of the American Society of Nephrology : CJASN2024

Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial.

Dana C Miskulin, Hocine Tighiouart, Caroline M Hsu, Daniel E Weiner

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical journal of the American Society of Nephrology : CJASN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Low dialysate sodium levels for chronic haemodialysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Review
  3. A Narrative Summary of Strategies to Mitigate Intradialytic Hypotension in Poisoned Patients Requiring Extracorporeal Toxin Elimination.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dana C MiskulinDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Hocine TighiouartInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0003-1448-327
Caroline M HsuDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-4660-1309
Daniel E WeinerDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-8775-394
Tufts Medical Center · USTufts University · US

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
Dialysis Clinics Inc. UL1TR002544NCATS NIH HHS UL1 TR002544NCATS NIH HHS UL1TR002544
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Renal DialysisAgedFemaleHemodialysis SolutionsHumansKidney Failure, ChronicMaleMiddle AgedSodiumTreatment OutcomeHemodialysis SolutionsSodium

Identifiers

PMID38349776
PMCPMC11168813
OpenAlexW4391787145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.